Related Articles
Sclareolide enhances gemcitabine‑induced cell death through mediating the NICD and Gli1 pathways in gemcitabine‑resistant human pancreatic cancer
Ribonucleotide reductase subunit M1 assessed by quantitative double-fluorescence immunohistochemistry predicts the efficacy of gemcitabine in biliary tract carcinoma
Establishment of human pancreatic cancer gemcitabine‑resistant cell line with ribonucleotide reductase overexpression
RRM1 is mediated by histone acetylation through gemcitabine resistance and contributes to invasiveness and ECM remodeling in pancreatic cancer
Preclinical rationale for synergistic interaction of pemetrexed and cytotoxic nucleoside analogues